CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 5, 2026
$300.02−0.13 (-0.04%)
Close on Oct 19, 2026
- Market cap
- $14.41B
- P/E (TTM)
- –
- Dividend yield
- –
Charles River Laboratories International statistics
Financials through Jun 27, 2026, price as of Oct 19, 2026, median of Services-Commercial Physical & Biological Research companies for comparison
Valuation
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Market Cap | $14.32B | $74.60M |
| Enterprise Value | $16.76B | $56.72M |
| PS Ratio | 3.58 | 3.25 |
| PB Ratio | 5.04 | 3.13 |
| P/FCF Ratio | 38.65 | 20.60 |
| P/OCF Ratio | 24.60 | 15.81 |
Enterprise value
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| EV / Sales | 4.19 | 2.79 |
| EV / EBITDA | 43.20 | 15.81 |
| EV / EBIT | 185.95 | 22.04 |
| EV / FCF | 45.23 | 21.35 |
Income (trailing twelve months)
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Revenue | $4.00B | $24.74M |
| Operating Income | $90.14M | -$55.64K |
| Net Income | -$238.46M | -$97.64K |
| EBITDA | $388.03M | -$29.48K |
| EPS (Diluted) | -$4.91 | $0.00 |
Margins
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Operating Margin | 2.25% | 0.94% |
| Profit Margin | -5.96% | 0.51% |
| EBITDA Margin | 9.70% | 3.48% |
| FCF Margin | 9.27% | 5.05% |
Returns
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Return on Equity (ROE) | -7.70% | 0.45% |
| Return on Assets (ROA) | -3.16% | -3.47% |
| Return on Invested Capital (ROIC) | 1.32% | 2.85% |
| Return on Capital Employed (ROCE) | 1.41% | 2.03% |
Growth
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -0.74% | 4.26% |
| FCF Growth (YoY) | -35.9% | -10.5% |
| Revenue Growth (3Y CAGR) | 0.33% | 2.15% |
| Revenue Growth (5Y CAGR) | 6.55% | 7.37% |
Balance sheet
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $192.03M | $5.43M |
| Total Debt | $2.63B | $85.44M |
| Net Cash (Debt) | -$2.43B | $17.62K |
| Net Cash Per Share | -$50.97 | $0.00 |
| Equity (Book Value) | $2.84B | $10.50M |
| Book Value Per Share | $59.48 | $0.60 |
| Tangible Book Value | -$490.39M | -$78.36K |
| Working Capital | $394.36M | $2.78M |
Financial position
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Current Ratio | 1.35 | 1.26 |
| Quick Ratio | 0.80 | 0.65 |
| Debt / Equity | 0.92 | 0.45 |
| Debt / EBITDA | 6.77 | 2.59 |
| Debt / FCF | 7.08 | 3.29 |
| Net Debt / EBITDA | 6.27 | 1.99 |
| Interest Coverage | 0.85 | -0.23 |
Cash flow (trailing twelve months)
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Operating Cash Flow | $582.15M | $8.04K |
| Capital Expenditures | -$211.54M | -$8.33M |
| Free Cash Flow | $370.61M | $11.03M |
| FCF Per Share | $7.76 | $0.76 |
Efficiency
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Asset Turnover | 0.53 | 0.83 |
| Revenue Per Employee | $202.99K | $216.23K |
| Profits Per Employee | -$12.10K | -$3.19K |
| Employee Count | 19,700 | 123 |
Dividends and yields
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Earnings Yield | -1.66% | -0.97% |
| FCF Yield | 2.59% | 3.90% |
| Buyback Yield | 2.26% | 1.36% |
| Shareholder Yield | 2.26% | 1.65% |
Shares
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Shares Outstanding | 47,738,900 | 29,217,800 |
| Shares Change (YoY) | -3.97% | 0.84% |
| Shares Change (QoQ) | -0.91% | 0.00% |
| Float | 47,148,000 | 26,226,050 |
| Shares Held by Insiders | 1.24% | 4.85% |
| Shares Held by Institutions | 119.1% | 83.3% |
Taxes
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Income Tax | $52.63M | $1.36M |
Scores
| Measure | Charles River Laboratories International | Industry median |
|---|---|---|
| Altman Z-Score | 2.74 | 2.66 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from Charles River Laboratories International's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.